SE0202924D0 - Compositions for preventing posterior capsular opacification and its use - Google Patents

Compositions for preventing posterior capsular opacification and its use

Info

Publication number
SE0202924D0
SE0202924D0 SE0202924A SE0202924A SE0202924D0 SE 0202924 D0 SE0202924 D0 SE 0202924D0 SE 0202924 A SE0202924 A SE 0202924A SE 0202924 A SE0202924 A SE 0202924A SE 0202924 D0 SE0202924 D0 SE 0202924D0
Authority
SE
Sweden
Prior art keywords
composition
lens
capsular bag
space
natural crystalline
Prior art date
Application number
SE0202924A
Other languages
Swedish (sv)
Inventor
Sverker Norrby
Original Assignee
Pharmacia Groningen Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Groningen Bv filed Critical Pharmacia Groningen Bv
Priority to SE0202924A priority Critical patent/SE0202924D0/en
Publication of SE0202924D0 publication Critical patent/SE0202924D0/en
Priority to AU2003265187A priority patent/AU2003265187A1/en
Priority to PCT/SE2003/001504 priority patent/WO2004030653A1/en
Priority to US10/677,932 priority patent/US20050191322A1/en
Priority to US12/489,247 priority patent/US20090259228A1/en

Links

Abstract

The present invention relates to a composition comprising a sterile ophthalmic composition, which comprises one or more agents capable of inhibiting lens epithelial proliferation (e.g. fluorouracil, saporin, mitomycin or doxorubicin), dissolved in a physiologically isotonic solution. The present invention also relates to a method of preventing capsular opacification by using said composition. The method comprises the steps of : creating an incision within an eye and a capsulorhexis in a capsular bag of said eye; inserting at least a portion of cannula in said capsulorhexis; separating the natural crystalline lens from the capsular bag by injecting through a cannula the composition in a manner that generates a space between the capsular bag and the natural crystalline lens; retaining the composition in said space between the capsule and the natural crystalline lens for a sufficient time for said composition to effectively kill or render non-proliferative lens epithelial cells in or adjacent to said space; removing the lens and said composition; inserting an implant into the capsular bag.
SE0202924A 2002-10-03 2002-10-03 Compositions for preventing posterior capsular opacification and its use SE0202924D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE0202924A SE0202924D0 (en) 2002-10-03 2002-10-03 Compositions for preventing posterior capsular opacification and its use
AU2003265187A AU2003265187A1 (en) 2002-10-03 2003-09-29 Compositions for preventing posterior capsular opacification and the use thereof
PCT/SE2003/001504 WO2004030653A1 (en) 2002-10-03 2003-09-29 Compositions for preventing posterior capsular opacification and the use thereof
US10/677,932 US20050191322A1 (en) 2002-10-03 2003-10-02 Compositions for preventing posterior capsular opacification and the use thereof
US12/489,247 US20090259228A1 (en) 2002-10-03 2009-06-22 Methods for Preventing Posterior Capsular Opacification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202924A SE0202924D0 (en) 2002-10-03 2002-10-03 Compositions for preventing posterior capsular opacification and its use

Publications (1)

Publication Number Publication Date
SE0202924D0 true SE0202924D0 (en) 2002-10-03

Family

ID=20289162

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202924A SE0202924D0 (en) 2002-10-03 2002-10-03 Compositions for preventing posterior capsular opacification and its use

Country Status (3)

Country Link
AU (1) AU2003265187A1 (en)
SE (1) SE0202924D0 (en)
WO (1) WO2004030653A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875270B2 (en) * 2002-09-17 2011-01-25 Abbott Medical Optics Inc. Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
US7985405B2 (en) 2002-09-17 2011-07-26 Jin Jun Zhang Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
GB0419145D0 (en) * 2004-08-27 2004-09-29 Univ Dundee Treatment of posterior capsule opacification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285006A1 (en) * 2000-08-21 2002-03-04 Bausch And Lomb Surgical, Inc. Prevention of posterior capsular opacification by endocapsular circulation of chemical agents

Also Published As

Publication number Publication date
AU2003265187A1 (en) 2004-04-23
WO2004030653A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
WO2006019893A3 (en) Intrastromal devices and method for improving vision
AR048646A1 (en) INTRAOCULAR IMPLANT OR BIODEGRADABLE INTRAVITREO THAT INCLUDES A THYROSINE KINASE INHIBITOR AND A BIODEGRADABLE POLYMER, METHOD TO PRODUCE IT AND CORRESPONDING MEDICATION
MX2014000629A (en) Intraocular implant cell migration inhibition system.
FR12C0067I1 (en) BIODEGRADABLE EYE IMPLANT
CY1121865T1 (en) OPHTHALMOLOGICAL COMPOSITIONS AND THEIR USE
DK0729323T3 (en) Corneal Implant
CY1110597T1 (en) CORRECTION OF UPPER CLASS DETECTORS IN INTRODUCTION LENS
BRPI0519097A2 (en) compositions for injectable ophthalmic lens
WO2006054178A3 (en) Thin iol
NO994485L (en) Controlled release of pharmaceutical agents in the anterior chamber of the eye
EA200802390A1 (en) CONSENTS OF ANALOGUES OF AZIRIDELEPOTILON AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE502633T1 (en) CYCLOSPORINS FOR THE TREATMENT AND PREVENTION OF EYE DISEASES
HK1113970A1 (en) Formulations for injection of catecholic butanes, including ndga compounds, into animals
WO2006133903A3 (en) Method, dye and medicament for staining the internal limiting memebrane, the vitreous and/or the capsule of an eye
AR070824A1 (en) SUSPENSIONS FOR INTRAVITREAL INJECTION OF LOW VISCOSITY ACETONID TRIAMCINOLONE, HIGHLY FLOCULATED
TW200518760A (en) Triamcinolone acetonide and anecortave acetate formulations for injection
HK1110207A1 (en) Ophthalmic compositions and methods of using the same
SE0202924D0 (en) Compositions for preventing posterior capsular opacification and its use
TW200719893A (en) Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery
ES2722723T3 (en) Methods to treat eye diseases associated with inflammation and vascular proliferation
HRP20050603A2 (en) Novel anticonvulsant derivative salts
WO2005048920A3 (en) Methods and compositions for protecting against cataract development associated with vitrectomies
Wolken et al. Linear posterior capsule opacification with the AcrySof intraocular lens
WO2006084044A3 (en) Surgical device for folding objects and methods of using the same
FR2869793B3 (en) DOUBLE-LENS INTRAOCULAR IMPLANT SYSTEM FOR CORRECTION OF LOW AND HIGH ORDER ABERRATIONS IN PSEUDO PHAQUE